Cargando…

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?

Detalles Bibliográficos
Autores principales:	O’Higgins, Marcelo G., Barrios, Juan I., Almirón-Santacruz, José D., Castaldelli-Maia, João M., Ventriglio, Antonio, Torales, Julio C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522619/ https://www.ncbi.nlm.nih.gov/pubmed/34789946 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_172_21

Ejemplares similares

COVID-19 infodemic and depressive symptoms: The impact of the exposure to news about COVID-19 on the general Paraguayan population
por: Torales, Julio, et al.
Publicado: (2022)

Anxiety, Addiction to Social Networks, Internet and Smartphones in Paraguayan Adolescents: A Brief Report
por: Figueredo, Pamela, et al.
Publicado: (2022)

Self-Perceived Stress During the Quarantine of COVID-19 Pandemic in Paraguay: An Exploratory Survey
por: Torales, Julio, et al.
Publicado: (2020)

Phone-based outpatients’ follow-up in mental health centers during the COVID-19 quarantine
por: Gentile, Alessandro, et al.
Publicado: (2020)

“Pandemic Fatigue” in South America: A Multi-Center Report from Argentina, Bolivia, Paraguay, Peru, and Uruguay
por: Torales, Julio, et al.
Publicado: (2023)

Homophobia and mental health: a scourge of modern era
por: Ventriglio, Antonio, et al.
Publicado: (2021)

Kleptomania as a neglected disorder in psychiatry
por: Torales, J., et al.
Publicado: (2021)

Use of Psychoeducation for Psychotic Disorder Patients Treated With Modern, Long-Acting, Injected Antipsychotics
por: Ventriglio, Antonio, et al.
Publicado: (2021)

Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-19
por: Ismael, Flavia, et al.
Publicado: (2021)

Ivermectin: Acute hepatocellular injury following off-label use: case report
Publicado: (2022)

A meta-analysis and meta-regression analysis of the global prevalence of obsessive-compulsive personality disorder
por: Clemente, Marina Junqueira, et al.
Publicado: (2022)

Major depressive disorder as a risk factor for suicidal ideation for attendees of educational institutions: a meta-analysis and meta-regression
por: Souza, Laura Costa, et al.
Publicado: (2023)

Azithromycin/ivermectin: Mixed hearing loss following off-label use: case report
Publicado: (2022)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

Experimentation with tobacco during adolescence as a factor influencing treatment of smoking in adulthood. A retrospective cohort
por: Chaim, Carolina Hanna, et al.
Publicado: (2019)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Ivermectin: Anti-neutrophil cytoplasmic antibody-associated vasculitis following off label use: case report
Publicado: (2021)

Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies
por: Florence, Luiza, et al.
Publicado: (2022)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023)

Substance Use in Mild-COVID-19 Patients: A Retrospective Study
por: Ismael, Flavia, et al.
Publicado: (2021)

Corrigendum: Substance Use in Mild-COVID-19 Patients: A Retrospective Study
por: Ismael, Flavia, et al.
Publicado: (2021)

Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review
por: de Oliveira, Mariana Campello, et al.
Publicado: (2023)

Is any awareness necessary for an Ne?
por: Shalgi, Shani, et al.
Publicado: (2012)

Parents’ awareness and perspective on off-label medicines use in children
por: Saiyed, Mohd Masnoon, et al.
Publicado: (2015)

The Use of Ivermectin in the Treatment of COVID-19
por: Shukla, Ajay Kumar, et al.
Publicado: (2023)

American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19
por: Calello, Diane P., et al.
Publicado: (2022)

Off-label use of rhBMP-2
por: Watts, Clark
Publicado: (2011)

Less explored off-label indications of dexmedetomidine
por: Nair, Abhijit
Publicado: (2017)

Clinico-epidemiological profile of patients at children’s psychosocial care centers in São Bernardo do Campo: a cross-sectional study
por: Messias, Maialu Pedreira, et al.
Publicado: (2022)

The off-label use, utility and potential value of tDCS in the clinical care of particular neuropsychiatric conditions
por: Bikson, Marom, et al.
Publicado: (2016)

In vivo uptake of labelled oestradiol by benign and malignant tumours of the human breast.
por: O'Higgins, N. J., et al.
Publicado: (1973)

Refusal to Treat Patients Does Not Work in Any Country—Even If Misleadingly Labeled “Conscientious Objection”
por: Fiala, Christian, et al.
Publicado: (2017)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

Anesthesiologist to surgeons’ rescue: An off label use of choledochoscope
por: Aggarwal, Shiba, et al.
Publicado: (2012)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Sex differences in smoking cessation: a retrospective cohort study in a psychosocial care unit in Brazil
por: Guimarães-Pereira, Bruna Beatriz Sales, et al.
Publicado: (2023)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uij6efq0tvvcumlv8i61itie1k